VivaBioCell
VivaBioCell develops products based on cell culture and tissue engineering for the diagnosis of autoimmune diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$2—3m (Dealroom.co estimates Jul 2007.)
Udine Friuli-Venezia Giulia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
€440k | Seed | ||
N/A | Acquisition | ||
| Total Funding | $484k | ||
Related Content
Recent News about VivaBioCell
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.